The Online Investor
Stock Buybacks
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Stock Buybacks

By The Online Investor Staff, updated Thu., May. 5, 4:28 AM

Slide #2. Cardinal Health

Company: Cardinal Health (NYSE:CAH)
$Amount Authorized: $1,000,000,000
Buyback Details: Cardinal Health today announced that its board of directors approved a 16 percent increase in the company's quarterly dividend to $0.4489 per share, or $1.80 per share on an annualized basis. The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2015. The board of directors also approved a new authorization to repurchase up to $1 billion of Cardinal Health common shares, which will expire on Dec. 31, 2019. The new share repurchase program is in addition to the program approved in August 2014, of which $393 million remains available.

Cardinal Health is a healthcare services and products company. Co.'s segments are: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products; operates nuclear pharmacies and cyclotron facilities; and distributes specialty pharmaceutical products, provides services to pharmaceutical manufacturers, third-party payors and healthcare providers, and provides specialty pharmacies services. The Medical segment distributes a range of medical, surgical and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers and to patients in the home.

Cardinal Health SEC Filing Email Alerts Service

Open the CAH Page at The Online Investor »

Company Name:  Cardinal Health, Inc.
Stock buyback:  CAH buyback
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding CAH:  89
Total Market Value Held by ETFs:  $1.11B
Total Market Capitalization:  $26.18B
% of Market Cap. Held by ETFs:  4.22%

Open the CAH Page at The Online Investor (in a new window) »

May 5, 2016    4:28 AM Eastern
Quotes delayed 20 minutes

Buy (3.15 out of 4)
51st percentile
(ranked higher than approx. 51% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Buybacks | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.